A Phase III, Open-Label, Multicenter, Randomized Study t

Project: Research project

Project Details

Description

A Phase III, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of MPDL3280A (ANTI-PD-L1 ANTIBODY)compared with Docetaxel in patients with non-small cell lung cancer after platinum failure
StatusFinished
Effective start/end date11/20/1311/20/19

Funding

  • Genentech Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.